A study of 302 dementia-free older adults in Southeast Asia, published in October 2026 in Alzheimer's & Dementia, found that narrower small arteries in the retina were linked to a higher chance of developing mild behavioral impairment, an early warning…
A real-world study of 181 people with Alzheimer's in China, published in October 2026 in Alzheimer's & Dementia, found that responses to lecanemab emerged at 6 months, mostly in early disease, and brain swelling occurred in 7.2%, all without symptoms.
In a study of 136 older adults published Oct. 30, 2026, in GeroScience, delayed recall on a face-name memory test told apart people with mild cognitive impairment about as well as the MoCA (AUC 0.711 vs. 0.705), with higher specificity.
A meta-analysis published Oct. 26, 2026, in GeroScience compared dementia risk scores. CAIDE did best, with an accuracy (AUC) of 0.74 to 0.76, especially in middle-aged people followed for longer; the original LIBRA did worst, at 0.51 to 0.60.
In a Medicare study published Oct. 1, 2026, in JAMA Network Open, people with dementia who had more annual wellness visits in the previous 3 years were more likely to start a dementia medicine, up to a 16.0% higher rate…
A genetic study of more than 2 million people published Oct. 28, 2026, in Nature identified 118 Alzheimer's risk regions in a multi-ancestry analysis, plus 9 more in specific ancestries, 48 of them new. Risk genes converged on the brain's…